Evolution of the National Breast Screening Programme in Ireland: Two-year interval analysis (2004–2013) of BreastCheck

Fitzpatrick, Patricia; Greehy, Gráinne M.; Mooney, Therese; Flanagan, Fidelma; Larke, A.; Connors, A M; O’Doherty, Ann

doi:10.1177/0969141317738034

Cited by 3 publications

(2 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The biopsy indication rate was close to that expected by the Irish program (≤ 2.0%), 17 as well that recorded in the 2019 ACR report 16 (1.66%), and that of Norwegian county programs (1.4%). 18 Moreover, the rate is intermediate if one considers the Canadian results.…”

Section: Discussionsupporting

confidence: 85%

Evaluation of breast cancer screening indicators in the female population using the National Health System, Brazil, 2018-2019: a descriptive study

Tomazelli¹,

Dias²,

Ribeiro³

et al. 2023

Epidemiol. Serv. Saúde

View full text Add to dashboard Cite

Objetivo: analisar indicadores de monitoramento do rastreamento do câncer de mama na população feminina usuária do Sistema Único de Saúde, Brasil, no período 2018-2019. Métodos: estudo descritivo, a partir do Sistema de Informação do Câncer; foram calculados indicadores de rastreamento após relacionamento determinístico das bases de dados de mamografia e histopatologia. Resultados: em 2018, 807.430 mulheres na faixa etária de 50-69 anos foram rastreadas e dessas, 91% apresentaram resultado benigno, 1,8% provavelmente benigno, 6,7% inconclusivo e 0,5% sugestivo de câncer; a taxa de mamografia positiva foi de 9,0%; estimou-se indicação de biópsia para 1,6% das mulheres, resultado maligno para 33,9% delas, e taxa de confirmação de câncer de 5,4 por 1000 mulheres. Conclusão: identificou-se elevada perda de seguimento das lesões benignas; a taxa de mamografias positivas foi inferior ao parâmetro internacional; contudo, a taxa de detecção de câncer foi adequada, e o percentual de mamografias inconclusivas aceitável.

show abstract

Section: Discussionsupporting

confidence: 85%

Evaluation of breast cancer screening indicators in the female population using the National Health System, Brazil, 2018-2019: a descriptive study

Tomazelli¹,

Dias²,

Ribeiro³

et al. 2023

Epidemiol. Serv. Saúde

View full text Add to dashboard Cite

show abstract

“…The following self-reported SDH were measured: age; education level; health insurance; region; employment status; and marital status. For age, participants were categorised as under 60 vs. 60 and older; this categorization aligns with the mid-point age for eligible breast screening in Ireland [29]. For education level, participants were categorised as low (primary/secondary) education vs. high (third-level/postgraduate) education.…”

Section: Sdh Covariatesmentioning

confidence: 99%

COVID-19, breast cancer care, and social determinants of health: a cross-sectional study to investigate the impact of a pandemic on health care and quality of life

Myers

Bennett

Kelly

et al. 2022

Preprint

View full text Add to dashboard Cite

Purpose The aim of this study is to understand the impact of COVID-19 on breast cancer (BC) services and quality of life (QoL) in women living with and beyond BC in Ireland and whether the impact varied by social determinants of health (SDH). Methods The survey study invited women diagnosed with BC in the past five years to complete a questionnaire measuring the impact of COVID-19, disruption to BC services, QoL, SDH, and clinical covariates during a period of COVID-19 restrictions. The association between COVID-19 impact, disruption to BC services, and QoL was assessed using logistic and linear regression respectively with adjustment for SDH and clinical covariates. Interactions between COVID-19 impact and SDH were explored. Results 30.5% of women reported a high COVID-19 impact, which was associated with younger age, urban living, and employment status. Over half of all women reported disrupted BC services. A high COVID-19 impact was associated with more disruption to BC services and lower QoL scores. Women in post-active treatment and further removed from their diagnosis reported significantly more disruption to BC services. Younger women and women not employed reported significantly lower QoL scores. Additionally, there were significant interactions between health insurance status and COVID-19 impact on both outcomes. Conclusion The COVID-19 pandemic has significantly impacted women with a prior diagnosis of BC in Ireland, and this impact varied by SDH, including age, region, employment status, and health insurance status. Further research is needed to understand the long-term impact of the pandemic on women with BC.

show abstract

Defining clinicopathological and radiological features of breast cancer in women under the age of 35: an epidemiological study

et al. 2020

View full text Add to dashboard Cite

Evolution of the National Breast Screening Programme in Ireland: Two-year interval analysis (2004–2013) of BreastCheck

Abstract: Revised indicators to reflect the digital mammography era are anticipated in revised European Guidelines on breast cancer screening.

Cited by 3 publications

References 21 publications

Evaluation of breast cancer screening indicators in the female population using the National Health System, Brazil, 2018-2019: a descriptive study

Evaluation of breast cancer screening indicators in the female population using the National Health System, Brazil, 2018-2019: a descriptive study

COVID-19, breast cancer care, and social determinants of health: a cross-sectional study to investigate the impact of a pandemic on health care and quality of life

Defining clinicopathological and radiological features of breast cancer in women under the age of 35: an epidemiological study

Contact Info

Product

Resources

About